ASPM predicts poor clinical outcome and promotes tumorigenesis for diffuse large B-cell lymphoma.

CONCLUSION: Collectively, our results suggested that ASPM potentially served as a predictive biomarker of DLCBL tumorigenesis and prognosis, representing a potential therapeutic target for DLCBL.
PMID: 32933462 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - September 13, 2020 Category: Cancer & Oncology Authors: Wu J, He Z, Zhu Y, Jiang C, Deng Y, Wei B Tags: Curr Cancer Drug Targets Source Type: research